Delivery Order SPE2DB24D2205-SPE2DB24FDURE
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,117.80 firm fixed price delivery order is for the supply of IPOL VIAL 5ML medical products. The contract has a period of performance through February 28, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle for...
- This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,163.64 firm fixed-price delivery order is for the supply of IPOL VIAL 5ML pharmaceutical products. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $32,468.30 firm-fixed-price delivery order is for the supply of IPOL VIAL 5ML, a medical product. The contract has a period of performance through November 2024 and is not designated with a set-aside requirement. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,668.52 firm fixed-price delivery order is for the supply of 4567951715 IPOL VIAL 5ML, with a performance period ending on April 18, 2025. The contract is not set aside and is considered an open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $8,538.80 firm fixed-price delivery order is for the supply of 4566133902 IPOL VIAL 5ML medical products, with an ultimate completion date of October 18, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,149.56 firm fixed-price delivery order is for the supply of IPOL VIAL 5ML medical products, with a period of performance through May 23, 2025. The contract is not set aside and represents an open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The $10,673.50 Firm Fixed Price delivery order is for the supply of 4564884108 IPOL VIAL 5ML, a pharmaceutical product. This award is under a larger Indefinite Delivery Contract (IDC) between DLA and Amerisourcebergen, valued up to $999,999,999.00 through December 31, 2025. The IDC serves as the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $21,347.00 firm-fixed-price delivery order is for the provision of 4566317976 IPOL VIAL 5ML medical products. The contract has an ultimate completion date of November 5, 2024 and was awarded on November 4, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,360.40 firm fixed-price delivery order contract is for the supply of 4566825386 ! IPOL VIAL 5ML medical products. The contract has an ultimate completion date of January 3, 2025 and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $103,895.16 firm fixed-price delivery order is for the supply of 4568733802 IPOL VIAL 5ML medical products. The contract has an ultimate completion date of July 9, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB24FDUREDelivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distribution company. The $3,415.52 firm-fixed-price delivery order is for the supply of 4564730251 IPOL VIAL 5ML, with a period of performance ending on May 29, 2024. This contract is not set aside and is part of Amerisourcebergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. Under this single-award IDC, Amerisourcebergen provides a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.4k | 5/28/24 |